US Stock MarketDetailed Quotes

CRSP CRISPR Therapeutics

Watchlist

51.620
-0.260-0.50%

Close Nov 8 16:00 ET

51.650
+0.030+0.06%

Post 20:01 ET

4.41BMarket Cap-18501P/E (TTM)

CRISPR Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-168.25%-106.91M

28.27%-95.58M

1,147.32%109.75M

47.48%-260.38M

15.23%-96.07M

62.12%-39.86M

6.14%-133.25M

106.51%8.8M

-191.98%-495.74M

-31.72%-113.33M

Net income from continuing operations

23.37%-85.94M

-62.60%-126.41M

-119.71%-116.59M

76.37%-153.61M

180.80%89.35M

35.75%-112.15M

58.17%-77.74M

70.39%-53.07M

-272.16%-650.18M

21.72%-110.58M

Depreciation and amortization

-3.78%4.74M

-2.34%4.85M

-4.32%4.83M

-17.93%19.84M

-16.18%4.9M

-1.85%4.93M

-31.75%4.96M

-16.36%5.05M

34.64%24.17M

-6.63%5.85M

Other non cash items

-33.69%-6.9M

-159.63%-8.18M

-765.33%-8.39M

-212.63%-14.05M

-2,276.26%-4.77M

-299.96%-5.16M

-188.21%-3.15M

-115.89%-969K

-11.62%12.47M

-95.33%219K

Change In working capital

-176.78%-40.36M

113.27%10.49M

470.33%210.49M

-1,075.49%-193.59M

-545.02%-203.97M

41.34%52.56M

-1,066.16%-79.08M

505.53%36.91M

-26.11%19.85M

-271.01%-31.62M

-Change in receivables

--0

--200M

-65,673.77%-200M

-408,263.27%-200M

411,664.71%70M

-91,009.09%-70M

--0

289.44%305K

132.03%49K

-Change in prepaid assets

-123.01%-188K

-39.98%2.35M

-75.51%2.95M

1,353.00%23.22M

218.05%6.45M

-83.76%817K

251.69%3.91M

161.11%12.04M

111.49%1.6M

-212.36%-5.46M

-Change in payables and accrued expense

-54.53%-38.16M

180.17%9.28M

-62.55%9.44M

-492.08%-20.25M

70.44%-9.19M

-188.32%-24.69M

-216.72%-11.58M

1,660.27%25.21M

-86.23%5.16M

-236.50%-31.1M

-Change in other current liabilities

128.18%31K

112.70%40K

-154.12%-432K

107.23%110K

7.80%705K

89.29%-110K

68.31%-315K

-10.39%-170K

71.33%-1.52M

-44.48%654K

-Change in other working capital

-131.19%-2.04M

-7.18%-1.18M

-730.51%-1.47M

-76.69%3.33M

-145.76%-1.94M

25.68%6.55M

-162.43%-1.1M

-105.72%-177K

63.92%14.3M

141.61%4.24M

Cash from discontinued investing activities

Operating cash flow

-168.25%-106.91M

28.27%-95.58M

1,147.32%109.75M

47.48%-260.38M

15.23%-96.07M

62.12%-39.86M

6.14%-133.25M

106.51%8.8M

-191.98%-495.74M

-31.72%-113.33M

Investing cash flow

Cash flow from continuing investing activities

-233.17%-161.6M

-158.50%-126.91M

-183.00%-97.8M

244.84%374.65M

53.60%-81.45M

38.74%121.35M

486.87%216.92M

202.89%117.83M

75.02%-258.66M

-1,913.91%-175.53M

Net PPE purchase and sale

89.66%-219K

80.11%-707K

76.43%-721K

74.53%-9.47M

88.08%-738K

64.80%-2.12M

63.08%-3.56M

80.07%-3.06M

54.49%-37.19M

32.58%-6.19M

Net intangibles purchase and sale

--0

----

---2.5M

--0

---1M

----

--0

Net investment purchase and sale

-229.66%-161.39M

-156.85%-126.2M

-180.30%-97.08M

274.57%386.62M

52.34%-80.72M

33.15%124.47M

577.97%221.98M

221.91%120.89M

76.78%-221.47M

-36,361.46%-169.34M

Cash from discontinued investing activities

Investing cash flow

-233.17%-161.6M

-158.50%-126.91M

-183.00%-97.8M

244.84%374.65M

53.60%-81.45M

38.74%121.35M

486.87%216.92M

202.89%117.83M

75.02%-258.66M

-1,913.91%-175.53M

Financing cash flow

Cash flow from continuing financing activities

519.54%9.64M

-102.78%-466K

5,561.25%305.93M

62.38%62.66M

1,471.39%38.94M

-89.70%1.56M

61.93%16.77M

-49.25%5.4M

-84.62%38.59M

-60.66%2.48M

Net common stock issuance

--6M

---1.01M

--280.75M

3,273.30%32.72M

--32.72M

--0

-99.55%970K

--0

Proceeds from stock option exercised by employees

133.74%3.64M

-96.74%546K

366.12%25.19M

-20.41%29.94M

150.93%6.22M

-89.00%1.56M

61.93%16.77M

-49.25%5.4M

-0.15%37.62M

-60.66%2.48M

Cash from discontinued financing activities

Financing cash flow

519.54%9.64M

-102.78%-466K

5,561.25%305.93M

62.38%62.66M

1,471.39%38.94M

-89.70%1.56M

61.93%16.77M

-49.25%5.4M

-84.62%38.59M

-60.66%2.48M

Net cash flow

Beginning cash position

8.63%495.99M

101.88%718.94M

79.00%401.07M

-76.16%224.06M

5.74%539.6M

-11.01%456.6M

-49.18%356.12M

-76.16%224.06M

-20.71%939.94M

-50.38%510.33M

Current changes in cash

-411.72%-258.88M

-321.97%-222.95M

140.76%317.89M

124.72%176.94M

51.61%-138.59M

3,243.38%83.05M

153.52%100.44M

155.22%132.03M

-191.55%-715.8M

-223.76%-286.38M

Effect of exchange rate changes

256.25%75K

-92.86%2K

-134.38%-11K

191.25%73K

-46.96%61K

52.00%-48K

141.18%28K

218.52%32K

-627.27%-80K

3,733.33%115K

End cash Position

-56.04%237.19M

8.63%495.99M

101.88%718.94M

79.00%401.07M

5.74%539.6M

-11.01%456.6M

-49.18%356.12M

-76.16%224.06M

Free cash flow

-149.29%-107.13M

30.38%-96.29M

1,799.49%109.03M

48.90%-272.35M

19.00%-96.81M

61.37%-42.97M

8.76%-138.3M

103.81%5.74M

-216.55%-532.93M

-25.52%-119.52M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-168.25%-106.91M	28.27%-95.58M	1,147.32%109.75M	47.48%-260.38M	15.23%-96.07M	62.12%-39.86M	6.14%-133.25M	106.51%8.8M	-191.98%-495.74M	-31.72%-113.33M
Net income from continuing operations	23.37%-85.94M	-62.60%-126.41M	-119.71%-116.59M	76.37%-153.61M	180.80%89.35M	35.75%-112.15M	58.17%-77.74M	70.39%-53.07M	-272.16%-650.18M	21.72%-110.58M
Depreciation and amortization	-3.78%4.74M	-2.34%4.85M	-4.32%4.83M	-17.93%19.84M	-16.18%4.9M	-1.85%4.93M	-31.75%4.96M	-16.36%5.05M	34.64%24.17M	-6.63%5.85M
Other non cash items	-33.69%-6.9M	-159.63%-8.18M	-765.33%-8.39M	-212.63%-14.05M	-2,276.26%-4.77M	-299.96%-5.16M	-188.21%-3.15M	-115.89%-969K	-11.62%12.47M	-95.33%219K
Change In working capital	-176.78%-40.36M	113.27%10.49M	470.33%210.49M	-1,075.49%-193.59M	-545.02%-203.97M	41.34%52.56M	-1,066.16%-79.08M	505.53%36.91M	-26.11%19.85M	-271.01%-31.62M
-Change in receivables	--0	--0	--200M	-65,673.77%-200M	-408,263.27%-200M	411,664.71%70M	-91,009.09%-70M	--0	289.44%305K	132.03%49K
-Change in prepaid assets	-123.01%-188K	-39.98%2.35M	-75.51%2.95M	1,353.00%23.22M	218.05%6.45M	-83.76%817K	251.69%3.91M	161.11%12.04M	111.49%1.6M	-212.36%-5.46M
-Change in payables and accrued expense	-54.53%-38.16M	180.17%9.28M	-62.55%9.44M	-492.08%-20.25M	70.44%-9.19M	-188.32%-24.69M	-216.72%-11.58M	1,660.27%25.21M	-86.23%5.16M	-236.50%-31.1M
-Change in other current liabilities	128.18%31K	112.70%40K	-154.12%-432K	107.23%110K	7.80%705K	89.29%-110K	68.31%-315K	-10.39%-170K	71.33%-1.52M	-44.48%654K
-Change in other working capital	-131.19%-2.04M	-7.18%-1.18M	-730.51%-1.47M	-76.69%3.33M	-145.76%-1.94M	25.68%6.55M	-162.43%-1.1M	-105.72%-177K	63.92%14.3M	141.61%4.24M
Cash from discontinued investing activities
Operating cash flow	-168.25%-106.91M	28.27%-95.58M	1,147.32%109.75M	47.48%-260.38M	15.23%-96.07M	62.12%-39.86M	6.14%-133.25M	106.51%8.8M	-191.98%-495.74M	-31.72%-113.33M
Investing cash flow
Cash flow from continuing investing activities	-233.17%-161.6M	-158.50%-126.91M	-183.00%-97.8M	244.84%374.65M	53.60%-81.45M	38.74%121.35M	486.87%216.92M	202.89%117.83M	75.02%-258.66M	-1,913.91%-175.53M
Net PPE purchase and sale	89.66%-219K	80.11%-707K	76.43%-721K	74.53%-9.47M	88.08%-738K	64.80%-2.12M	63.08%-3.56M	80.07%-3.06M	54.49%-37.19M	32.58%-6.19M
Net intangibles purchase and sale	--0	----	----	---2.5M	--0	---1M	----	----	--0	--0
Net investment purchase and sale	-229.66%-161.39M	-156.85%-126.2M	-180.30%-97.08M	274.57%386.62M	52.34%-80.72M	33.15%124.47M	577.97%221.98M	221.91%120.89M	76.78%-221.47M	-36,361.46%-169.34M
Cash from discontinued investing activities
Investing cash flow	-233.17%-161.6M	-158.50%-126.91M	-183.00%-97.8M	244.84%374.65M	53.60%-81.45M	38.74%121.35M	486.87%216.92M	202.89%117.83M	75.02%-258.66M	-1,913.91%-175.53M
Financing cash flow
Cash flow from continuing financing activities	519.54%9.64M	-102.78%-466K	5,561.25%305.93M	62.38%62.66M	1,471.39%38.94M	-89.70%1.56M	61.93%16.77M	-49.25%5.4M	-84.62%38.59M	-60.66%2.48M
Net common stock issuance	--6M	---1.01M	--280.75M	3,273.30%32.72M	--32.72M	--0	--0	--0	-99.55%970K	--0
Proceeds from stock option exercised by employees	133.74%3.64M	-96.74%546K	366.12%25.19M	-20.41%29.94M	150.93%6.22M	-89.00%1.56M	61.93%16.77M	-49.25%5.4M	-0.15%37.62M	-60.66%2.48M
Cash from discontinued financing activities
Financing cash flow	519.54%9.64M	-102.78%-466K	5,561.25%305.93M	62.38%62.66M	1,471.39%38.94M	-89.70%1.56M	61.93%16.77M	-49.25%5.4M	-84.62%38.59M	-60.66%2.48M
Net cash flow
Beginning cash position	8.63%495.99M	101.88%718.94M	79.00%401.07M	-76.16%224.06M	5.74%539.6M	-11.01%456.6M	-49.18%356.12M	-76.16%224.06M	-20.71%939.94M	-50.38%510.33M
Current changes in cash	-411.72%-258.88M	-321.97%-222.95M	140.76%317.89M	124.72%176.94M	51.61%-138.59M	3,243.38%83.05M	153.52%100.44M	155.22%132.03M	-191.55%-715.8M	-223.76%-286.38M
Effect of exchange rate changes	256.25%75K	-92.86%2K	-134.38%-11K	191.25%73K	-46.96%61K	52.00%-48K	141.18%28K	218.52%32K	-627.27%-80K	3,733.33%115K
End cash Position	-56.04%237.19M	8.63%495.99M	101.88%718.94M	79.00%401.07M	79.00%401.07M	5.74%539.6M	-11.01%456.6M	-49.18%356.12M	-76.16%224.06M	-76.16%224.06M
Free cash flow	-149.29%-107.13M	30.38%-96.29M	1,799.49%109.03M	48.90%-272.35M	19.00%-96.81M	61.37%-42.97M	8.76%-138.3M	103.81%5.74M	-216.55%-532.93M	-25.52%-119.52M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	--	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data